“More people blame Brexit than anything else for supply problems, survey finds.” https://www.theguardian.com/society/article/2024/jun/16/almost-half-uk-adults-struggling-prescription-drugs-medicine-shortages?CMP=share_btn_url
The UK’s drug regulator, the MHRA, has taken a hit in terms of capacity and funding post-Brexit, and could benefit…
Report from Nuffield Trust health think-tank highlights impact of leaving EU on medicine supply chains. Read More
“Since leaving the EU in 2020, shortages have become the ‘new normal’.” https://news.sky.com/story/brexit-has-made-uk-medicine-shortages-worse-research-suggests-13117617
Nearly eight years after the UK voted to leave the European Union (EU), the government is still delaying on introducing…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) recently approved Amgen’s bone cancer drug Xgeva (denosumab), the first drug … Read…
“The Association of the British Pharmaceutical Industry (ABPI) trade organisation has broadly welcomed the addition of a new route…
Over half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. Read More
Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment The Swiss pharmaceutical…
The burden of having to produce separate product packs for Great Britain and Northern Ireland is among a number of…